NASDAQ · Drug Manufacturers - General
Gilead Sciences Inc (GILD)
$166.43
-0.06%
55
In band
Moving averages
SMA 200$141.29+17.79%
Company profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$210.52B
P/E ratioNone
EPS$-3.13
Beta0.372
Dividend yield1.90%
52-week high$176.58
52-week low$114.81
Similar stocks in Drug Manufacturers - General
RSI alerts for GILD
An email when GILD closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 12:06 AM EST